55 related articles for article (PubMed ID: 25102300)
1. Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.
Munkhdelger J; Kim G; Wang HY; Lee D; Kim S; Choi Y; Choi E; Park S; Jin H; Park KH; Lee H
Exp Mol Pathol; 2014 Oct; 97(2):279-84. PubMed ID: 25102300
[TBL] [Abstract][Full Text] [Related]
2. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
Sun J; Yue Y; Li R; Sun Q; Hu C; Ge X; Guan Q
Am J Transl Res; 2021; 13(6):7312-7317. PubMed ID: 34306499
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of HPV E6/E7 mRNA in screening for cervical intraepithelial neoplasia grade 2 or worse: A systematic review and meta‑analysis.
Xu F; Ran T; Wei Q; Pan R; Chen S; Luo J
Oncol Lett; 2024 May; 27(5):231. PubMed ID: 38586199
[TBL] [Abstract][Full Text] [Related]
4. Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.
Bellosillo B; Ibáñez R; Roura E; Monfil L; Asensio-Puig L; Álvarez I; Muset M; Florencia Y; Paytubi S; de Andrés-Pablo Á; Calvo S; Serrano-Munné L; Pavón MÁ; Lloveras B
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611001
[TBL] [Abstract][Full Text] [Related]
5. Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.
Nakowong P; Chatchawal P; Chaibun T; Boonapatcharoen N; Promptmas C; Buajeeb W; Lee SY; Jearanaikoon P; Lertanantawong B
Talanta; 2024 Mar; 269():125495. PubMed ID: 38043336
[TBL] [Abstract][Full Text] [Related]
6. HPV integration and cervical cancer: a failed evolutionary viral trait.
Molina MA; Steenbergen RDM; Pumpe A; Kenyon AN; Melchers WJG
Trends Mol Med; 2024 Jun; ():. PubMed ID: 38853085
[TBL] [Abstract][Full Text] [Related]
7. Polyhexamethylene Biguanide Reduces High-Risk Human Papilloma Virus Viral Load in Cervical Cell Samples Derived from ThinPrep Pap Test.
Di Fraia L; Babalini C; Calcagno M; Proietti S; Lepore E; Di Fraia P
Curr Issues Mol Biol; 2024 May; 46(5):4874-4884. PubMed ID: 38785561
[TBL] [Abstract][Full Text] [Related]
8. Application of CytoPath®Easy Vials in Cervical Cancer Screening: Self-Sampling Approach.
Fernandes SPM; Vilarinho AS; Frutuoso A; Teixeira C; Silva RAAP
J Cytol; 2024; 41(2):67-74. PubMed ID: 38779609
[TBL] [Abstract][Full Text] [Related]
9. Signal amplification by glyco-qPCR for ultrasensitive detection of carbohydrates: applications in glycobiology.
Kwon SJ; Lee KB; Solakyildirim K; Masuko S; Ly M; Zhang F; Li L; Dordick JS; Linhardt RJ
Angew Chem Int Ed Engl; 2012 Nov; 51(47):11800-4. PubMed ID: 23073897
[No Abstract] [Full Text] [Related]
10. Cervical Screening Using HPV mRNA: A New Modality.
Anand N; Pradeep Y; Srivastava A; Parikh S
J Midlife Health; 2024; 15(1):25-28. PubMed ID: 38764922
[No Abstract] [Full Text] [Related]
11. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
[TBL] [Abstract][Full Text] [Related]
13. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
14. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.
Wright TC; Stoler MH; Behrens CM; Sharma A; Zhang G; Wright TL
Gynecol Oncol; 2015 Feb; 136(2):189-97. PubMed ID: 25579108
[TBL] [Abstract][Full Text] [Related]
15. mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.
Del Pino M; Svanholm-Barrie C; Torné A; Marimon L; Gaber J; Sagasta A; Persing DH; Ordi J
Mod Pathol; 2015 Feb; 28(2):312-20. PubMed ID: 25189639
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China.
Yang L; Yang H; Wu K; Shi X; Ma S; Sun Q
J Med Virol; 2014 Nov; 86(11):1926-36. PubMed ID: 25111286
[TBL] [Abstract][Full Text] [Related]
17. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
[TBL] [Abstract][Full Text] [Related]
18. Screening and Early Diagnosis in Gynecological Cancers.
Giannella L; Ciavattini A
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958325
[TBL] [Abstract][Full Text] [Related]
19. Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression.
Liu H; Liang H; Li D; Wang M; Li Y
Microbiol Spectr; 2022 Oct; 10(5):e0015122. PubMed ID: 36036584
[TBL] [Abstract][Full Text] [Related]
20. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers.
Holcakova J; Bartosik M; Anton M; Minar L; Hausnerova J; Bednarikova M; Weinberger V; Hrstka R
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
